Sunday, March 09, 2025 | 11:37 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Moderna discards 400,000 Covid-19 vaccines, says will meet production goal

The loss is somewhat of a drop in the bucket for Moderna's overarching objective of producing 500 million to 1 billion doses in 2021

moderna
Premium

Moderna has been co-developing its Covid-19 candidate with the National Institute of Allergy and Infectious Diseases, a unit of the National Institutes of Health

Riley Griffin | Bloomberg
Moderna Inc. had to discard 400,000 doses of its experimental Covid-19 shot after a filtration issue compromised the product during the final stages of manufacturing, a U.S. official said Thursday.
 
Moncef Slaoui, Operation Warp Speed’s chief scientific adviser, disclosed Moderna’s manufacturing hiccup in an interview with Bloomberg News. The 400,000 doses, which weren’t yet placed in vials, were part of a broader 1.4 million batch of its vaccine, Slaoui said.

Moderna, however, remains on track to meet its production estimates of 20 million doses this month, and 85 to 100 million doses for the U.S. in the first quarter of 2021,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in